[CAPITALA] QoQ TTM Result on 30-Jun-2018 [#2]

Stock
[CAPITALA] CAPITAL A BERHAD
Announcement Date
30-Aug-2018
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2018
Quarter
30-Jun-2018 [#2]
Profit Trend
QoQ- 9.94%
YoY- 50.6%
Quarter Report
Latest QR
Upcoming QR
CAPITALA's Result
CAPITALA's Financial Summary
View:
Show?
TTM Result
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Revenue 10,936,835 10,610,990 10,445,048 10,284,066 10,038,786 9,710,158 8,989,483 13.97%
PBT 426,410 1,406,443 2,352,155 2,529,644 2,641,444 2,088,433 1,863,360 -62.62%
Tax 337,459 346,158 291,704 -255,490 -542,692 -495,774 -240,195 -
NP 763,869 1,752,601 2,643,859 2,274,154 2,098,752 1,592,659 1,623,165 -39.52%
-
NP to SH 978,810 2,024,706 2,792,326 2,381,775 2,166,480 1,640,305 1,732,975 -31.69%
-
Tax Rate -79.14% -24.61% -12.40% 10.10% 20.55% 23.74% 12.89% -
Total Cost 10,172,966 8,858,389 7,801,189 8,009,912 7,940,034 8,117,499 7,366,318 24.03%
-
Net Worth 8,254,676 6,216,071 8,622,292 8,221,256 7,953,898 6,383,170 6,216,071 20.83%
Dividend
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Div 4,745,603 1,737,826 1,336,789 - - - - -
Div Payout % 484.83% 85.83% 47.87% - - - - -
Equity
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Net Worth 8,254,676 6,216,071 8,622,292 8,221,256 7,953,898 6,383,170 6,216,071 20.83%
NOSH 3,341,974 3,341,974 3,341,974 3,341,974 3,341,974 3,341,974 3,341,974 0.00%
Ratio Analysis
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
NP Margin 6.98% 16.52% 25.31% 22.11% 20.91% 16.40% 18.06% -
ROE 11.86% 32.57% 32.38% 28.97% 27.24% 25.70% 27.88% -
Per Share
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
RPS 327.26 317.51 312.54 307.72 300.38 290.55 268.99 13.97%
EPS 29.29 60.58 83.55 71.27 64.83 49.08 51.85 -31.68%
DPS 142.00 52.00 40.00 0.00 0.00 0.00 0.00 -
NAPS 2.47 1.86 2.58 2.46 2.38 1.91 1.86 20.83%
Adjusted Per Share Value based on latest NOSH - 3,341,974
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
RPS 252.64 245.11 241.28 237.56 231.89 224.30 207.65 13.98%
EPS 22.61 46.77 64.50 55.02 50.04 37.89 40.03 -31.69%
DPS 109.62 40.14 30.88 0.00 0.00 0.00 0.00 -
NAPS 1.9068 1.4359 1.9917 1.8991 1.8373 1.4745 1.4359 20.83%
Price Multiplier on Financial Quarter End Date
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Date 29/03/19 31/12/18 28/09/18 29/06/18 30/03/18 29/12/17 29/09/17 -
Price 2.66 2.97 3.16 2.99 3.93 3.35 3.45 -
P/RPS 0.81 0.94 1.01 0.97 1.31 1.15 1.28 -26.31%
P/EPS 9.08 4.90 3.78 4.20 6.06 6.83 6.65 23.10%
EY 11.01 20.40 26.44 23.84 16.50 14.65 15.03 -18.75%
DY 53.38 17.51 12.66 0.00 0.00 0.00 0.00 -
P/NAPS 1.08 1.60 1.22 1.22 1.65 1.75 1.85 -30.17%
Price Multiplier on Announcement Date
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Date 29/05/19 27/02/19 29/11/18 30/08/18 24/05/18 27/02/18 29/11/17 -
Price 2.63 3.04 2.98 3.44 3.23 4.46 3.17 -
P/RPS 0.80 0.96 0.95 1.12 1.08 1.54 1.18 -22.84%
P/EPS 8.98 5.02 3.57 4.83 4.98 9.09 6.11 29.29%
EY 11.14 19.93 28.04 20.72 20.07 11.00 16.36 -22.61%
DY 53.99 17.11 13.42 0.00 0.00 0.00 0.00 -
P/NAPS 1.06 1.63 1.16 1.40 1.36 2.34 1.70 -27.03%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment